Prevalence and disease association of hepatitis G virus infection in Japan

Journal of Viral Hepatitis

Volumn 3, Issue 6, 1996, Pages 307-316

  Nakatsuji, Y ^a,b   Wai Kuo Shih, J ^a   Tanaka, E ^b   Kiyosawa, K ^b   Wages Jr , J ^c   Kim, J P ^c   Alter, H J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Genelabs Incorporated   (United States)

Author keywords

Dual viral infection; Hepatitis G virus; Non A E hepatitis; Parenteral transmission; Quantification of HGV RNA; RT PCR

Indexed keywords

VIRUS RNA;

ACUTE DISEASE; ADULT; ARTICLE; BLOOD; BLOOD DONOR; CHRONIC DISEASE; FEMALE; FLAVIVIRUS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; JAPAN; MALE; MIDDLE AGED; PREVALENCE; RENAL REPLACEMENT THERAPY; VIROLOGY; VIRUS HEPATITIS;

ACUTE DISEASE; ADULT; BLOOD DONORS; CHRONIC DISEASE; FEMALE; FLAVIVIRIDAE; HEPATITIS, VIRAL, HUMAN; HUMANS; JAPAN; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; RNA, VIRAL;

EID: 0030278358     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2893.1996.tb00103.x     Document Type: Article

References (31)

1. Alter HJ, Purcell RH, Shih JW et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494-1500.
2. Aach RD, Stevens CE, Hollinger FB et al. Hepatitis C virus infection in post-transfusion hepatitis. N Engl J Med 1991; 325: 1325-1329.
3. Alter MJ, Margolis HS, Krawczynski K et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1889-1905.
4. Blajchman MA, Bull SB, Feinman V, for the Canadian Post-Transfusion Hepatitis Prevention Study Group: Post-transfusion hepatitis: Impact of non-A, non-B hepatitis surrogate tests. Lancet 1995; 345: 21-25.
5. Tassopoulos NC, Hatzakis A, Kuhns M et al. Clinical and laboratory features of acute community-acquired non-A, non-B, non-C hepatitis. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral Hepatitis and Liver Disease. Proceedings of the 1993 International Symposium on Viral Hepatitis and Liver Disease. Tokyo: Springer-Verlag, 1994.
6. Alter HJ, Bradley DW. Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC). Semin Liver Dis 1995; 15: 110-120.
7. Linnen J, Wages J, Zhang-Keck ZY et al. Molecular cloning and disease association of hepatitis G virus: a new transfusion transmissible agent. Science 1996; 271: 505-508.
8. Simons JN, Leary TP, Dawson GJ et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1: 564-569.
9. Leary TP, Muerhoff AS, Simons JN et al. Sequence and genomic organization of GBV-C: a novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996; 48: 60-67.
10. Johnson PJ, McFarlane IG, Convenors, on behalf of the panel. Meeting report: International autoimmune hepatitis group. Hepatology 1993; 18: 998-1005.
11. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1987; 316: 521-528.
12. Chomczynski P, Sachi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
13. Nakatsuji Y, Matsumoto A, Tanaka E, Ogata H, Kiyosawa K. Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and polymerase chain reaction analysis. Hepatology 1992; 16: 300-305.
14. Shih JW-K, Cheung LC, Alter HJ, Lee LM, Gu JR. Strain analysis of hepatitis B virus on the basis of restriction endonuclease analysis of polymerase chain reaction products. J Clin Microbiol 1991; 29: 1640-1644.
15. Nolte FS, Thurmond C, Fried MW. Preclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNA. J Clin Microbiol 1995; 33: 1775-1778.
16. Muerhoff AS, Leary TP, Simons JN et al. Genomic organization of GB viruses A and B; two new members of the Flaviviridae associated with GB agent hepatitis. J Virol 1995; 69: 5621-5630.
17. Schlauder GG, Dawson GJ, Simons JN et al. Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol 1995; 46: 81-90.
18. Simons JN, Pilot-Matias TJ, Leary TP et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995; 92: 3401-3405.
19. Watanabe J, Matsumoto C, Fujimura K et al. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Vox Sang 1993; 65: 199-203.
20. Suzuki H. Viral hepatitis in Japan. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral Hepatitis and Liver Disease. Proceedings of the 1993 International Symposium on Viral Hepatitis and Liver Disease. Tokyo: Springer-Verlag, 1994.
21. Hess G, Horsch A, Hadziyannis S et al. The prevalence of a new hepatitis virus (HGV) in patients with liver disease and in groups at high risk of exposure to blood and blood products (abstract). Transfusion 1995; 35 (Suppl): 56S.
22. Kleinman S, Alter H, Busch P et al. Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 1992; 32: 805-813.
23. Kuo G, Choo Q-L, Alter HJ et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-364.
24. Fagan EA, Ellis DS, Tovey GM et al. Toga virus-like particles in acute liver failure attributed to sporadic non-A, non-B hepatitis and recurrence after liver transplantation. J Med Virol 1992; 38: 71-77.
25. Wright TL. Etiology of fulminant hepatic failure: Is another virus involved? Gastroenterology 1993; 104: 640-653.
26. Hibbs JR, Frickhofen N, Rosenfeld SJ et al. Aplastic anemia and viral hepatitis: Non-A, Non-B, Non-C? J Am Med Assoc 1992; 267: 2051-2054.
27. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-1132.
28. Kao J-H, Chen P-J, Chen D-S. GBV-C in the aetiology of fulminant hepatitis. Lancet 1996; 347: 120.
29. Kuroki T, Nishiguchi S, Tanaka M, Enomoto M, Kobayashi K. Does GBV-C cause fulminant hepatitis in Japan? Lancet 1996; 347: 908.
30. Young NS. Flaviviruses and bone marrow failure. J Am Med Assoc 1990; 263: 3065-3068.
31. Nakao S, Lai CJ, Young NS. Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines. Blood 1989; 74: 1235-1240.